Search

Author/Creator Jones, Robin L

25. Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer. Issue 2 (8th December 2010)

Authors:
Jones, Robin L; Rojo, Federico; A'Hern, Roger; Villena, Nadia; Salter, Janine; Corominas, Josep Maria; Servitja, Sonia; Smith, Ian E; Rovira, Ana; Reis-Filho, Jorge S; Dowsett, Mitchell; Albanell, Joan
Journal:
Journal of clinical pathology
Issue:
Volume 64:Issue 2(2011)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Issue 10043 (30th July 2016)

Authors:
Tap, William D; Jones, Robin L; Van Tine, Brian A; Chmielowski, Bartosz; Elias, Anthony D; Adkins, Douglas; Agulnik, Mark; Cooney, Matthew M; Livingston, Michael B; Pennock, Gregory; Hameed, Meera R; Shah, Gaurav D; Qin, Amy; Shahir, Ashwin; Cronier, Damien M; Ilaria, Robert; Conti, Ilaria; Cosae...
Journal:
Lancet
Issue:
Volume 388:Issue 10043(2016)
Page Start:
488
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients. (22nd September 2022)

Authors:
Stansfeld, Anna; Radia, Utsav; Goggin, Caitriona; Mahalingam, Preethika; Benson, Charlotte; Napolitano, Andrea; Jones, Robin L; Rosen, Stuart D; Karavasilis, Vasilios
Journal:
Expert opinion on pharmacotherapy
Issue:
Volume 23:Number 14(2022)
Page Start:
1641
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗